Charles Schwab Investment Management Inc. Purchases 89,926 Shares of American Healthcare REIT, Inc. (NYSE:AHR)

Charles Schwab Investment Management Inc. lifted its position in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 4.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,235,051 shares of the company’s stock after acquiring an additional 89,926 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.42% of American Healthcare REIT worth $67,722,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in AHR. Vanguard Group Inc. grew its position in American Healthcare REIT by 22.4% in the 1st quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company’s stock worth $569,494,000 after purchasing an additional 3,437,861 shares during the period. Northern Trust Corp grew its position in American Healthcare REIT by 99.0% in the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company’s stock worth $49,249,000 after purchasing an additional 861,882 shares during the period. Waterfront Capital Partners LLC bought a new stake in American Healthcare REIT in the 4th quarter worth approximately $15,066,000. Adage Capital Partners GP L.L.C. grew its position in American Healthcare REIT by 115.1% in the 4th quarter. Adage Capital Partners GP L.L.C. now owns 925,000 shares of the company’s stock worth $26,288,000 after purchasing an additional 495,000 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in American Healthcare REIT in the 1st quarter worth approximately $13,384,000. Institutional investors own 16.68% of the company’s stock.

Insider Buying and Selling at American Healthcare REIT

In other news, CIO Stefan K.L. Oh sold 3,860 shares of the business’s stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $36.10, for a total value of $139,346.00. Following the sale, the executive directly owned 95,671 shares in the company, valued at $3,453,723.10. The trade was a 3.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.92% of the stock is currently owned by company insiders.

American Healthcare REIT Stock Performance

Shares of NYSE AHR opened at $40.43 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.38 and a current ratio of 0.48. The company has a market cap of $6.45 billion, a P/E ratio of -183.77, a P/E/G ratio of 2.26 and a beta of 1.08. The firm’s fifty day moving average is $37.33 and its two-hundred day moving average is $32.99. American Healthcare REIT, Inc. has a 52-week low of $18.01 and a 52-week high of $41.50.

American Healthcare REIT (NYSE:AHR) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.02. The company had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. American Healthcare REIT’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.33 EPS. As a group, analysts anticipate that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 18th. Stockholders of record on Monday, June 30th were issued a $0.25 dividend. The ex-dividend date was Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.5%. American Healthcare REIT’s payout ratio is -454.55%.

Analyst Ratings Changes

AHR has been the subject of a number of research analyst reports. Jefferies Financial Group initiated coverage on shares of American Healthcare REIT in a research report on Monday, April 28th. They issued a “buy” rating and a $37.00 target price for the company. Morgan Stanley lifted their price target on shares of American Healthcare REIT from $37.00 to $45.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 20th. Scotiabank began coverage on shares of American Healthcare REIT in a research note on Monday, June 30th. They set a “sector outperform” rating and a $42.00 price target on the stock. Royal Bank Of Canada set a $45.00 price target on shares of American Healthcare REIT and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Truist Financial lifted their price target on shares of American Healthcare REIT from $32.00 to $38.00 and gave the stock a “buy” rating in a research note on Monday, June 9th. Ten research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $40.44.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.